Hi, what are you looking for?
Telix Pharmaceuticals Limited has submitted a marketing authorization application (MAA) in Europe for its glioma imaging candidate, TLX101-Px (O-(2-[18 F]fluoroethyl)-L-tyrosine, 18 F-FET). The announcement,...